Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB1 | P20618 | 1/20 | 0.52 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.52 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.52 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 13/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4746749 | 1.00 | PSMB1 (0.52) | PSMB1PSMB5PSMB2KCNA5HRH3 | |
| SCHEMBL4746751 | 0.97 | KCNA5 (0.51) | PSMB1PSMB5PSMB2KCNA5HRH3 | |
| SCHEMBL4743288 | 0.86 | HRH3 (0.56) | KCNA5HRH3MEN1KMT2AHRH4 | |
| SCHEMBL4743111 | 0.86 | HRH3 (0.56) | KCNA5HRH3MEN1KMT2AHRH4 | |
| SCHEMBL4745390 | 0.86 | HRH3 (0.50) | KCNA5HRH3MEN1KMT2A | |
| SCHEMBL4745392 | 0.86 | HRH3 (0.50) | KCNA5HRH3MEN1KMT2A | |
| SCHEMBL4743293 | 0.85 | MEN1 (0.56) | KCNA5HRH3MEN1KMT2AHRH4 | |
| SCHEMBL4747584 | 0.85 | HRH3 (0.47) | KCNA5HRH3MEN1KMT2A | |
| SCHEMBL4746716 | 0.84 | HRH3 (0.58) | KCNA5HRH3MEN1KMT2A | |
| SCHEMBL4746230 | 0.83 | HRH3 (0.53) | KCNA5HRH3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008107320-A1 | PIPERIDINE AND PIPERAZINE DERIVATIVES USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS | CEREP (FR) | 2008-09-12 | — | — | WO | disclosed |